MERCURY VCO2— 510(k) K092217

Name: FDA 510(k) clearance K092217
Creator: U.S. Food and Drug Administration
Published: 2009-08-21

Substantially Equivalent

Respironics Novametrix, Inc.

FDA 510(k) clearance K092217 for MERCURY VCO2, Substantially Equivalent on 2009-08-21. Applicant: Respironics Novametrix, Inc.. Device class: 2.

Clearance details

Applicant: Respironics Novametrix, Inc.
Product code: Code BZK
Device class: Class 2
Regulation: 21 CFR 868.1850
Advisory panel: Anesthesiology
Date received: 2009-07-22
Decision date: 2009-08-21
Decision: Substantially Equivalent
Clearance type: Special
Location: Wallingford, CT, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code BZK

view all

K192584 — BEACON Caresystem Model 000021442019-12-18
K192595 — ExSpiron 2Xi2019-12-17
K180788 — Gas Module 32018-10-24
K173181 — ExSpiron 1Xi2018-03-16
K162131 — ExSpiron 1Xi2017-05-09

More clearances from Respironics Novametrix, Inc.

view all

K042601 — CAPNOSTAT 52004-11-19
K032971 — TIDAL WAVE SP MODEL 710/715 AND 7152004-08-26
K032949 — SPOT CHECK PULSE OXIMETER,512/5132004-08-23
K041450 — MODIFICATION TO NICO WITH MARS, MODEL 73002004-06-18
K032755 — MODEL 509M PULSE OXIMETER, MODEL 509M2004-05-21

Adverse events under product code BZK

product code BZK

Death: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.